Carumonam
Carumonam is an antibiotic that belongs to the monobactam class of antibiotics. It is a synthetic antibiotic, meaning it is not derived from natural sources. Carumonam was developed in the 1980s and has been used in the treatment of various bacterial infections.
History[edit | edit source]
Carumonam was first synthesized in the 1980s by the Japanese pharmaceutical company Otsuka Pharmaceutical. It was developed as part of a broader effort to create new antibiotics that could combat resistant strains of bacteria.
Mechanism of Action[edit | edit source]
Like other monobactams, Carumonam works by inhibiting the synthesis of the bacterial cell wall. It does this by binding to penicillin-binding proteins (PBPs), which are essential for cell wall synthesis in bacteria. By inhibiting these proteins, Carumonam prevents the bacteria from forming a complete cell wall, which ultimately leads to the death of the bacteria.
Clinical Use[edit | edit source]
Carumonam has been used in the treatment of a variety of bacterial infections, including urinary tract infections, respiratory tract infections, and skin and soft tissue infections. It is particularly effective against Gram-negative bacteria, including resistant strains.
Side Effects[edit | edit source]
As with all antibiotics, Carumonam can cause side effects. These can include nausea, vomiting, diarrhea, and rash. In rare cases, it can cause more serious side effects such as anaphylaxis.
Resistance[edit | edit source]
While Carumonam is effective against many strains of bacteria, some bacteria have developed resistance to it. This is often due to the production of beta-lactamase enzymes, which can break down the antibiotic and render it ineffective.
See Also[edit | edit source]
Resources[edit source]
Latest articles - Carumonam
AI tools[edit source]
Generative AI tools and links to learn more on Carumonam: ChatGPT - Bing Chat - Google Gemini. (caution advised).
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD